Published in Am J Hematol on February 21, 2014
KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis. Leukemia (2015) 0.95
Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications. Mod Pathol (2015) 0.90
Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome? Front Immunol (2014) 0.84
The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease. Allergy (2014) 0.81
Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes. F1000Res (2016) 0.77
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet (2016) 0.77
Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM). PLoS One (2016) 0.75
The role of serum tryptase in the diagnosis and monitoring of pediatric mastocytosis: a single-center experience. Postepy Dermatol Alergol (2017) 0.75
Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature. Oncotarget (2016) 0.75
Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Clin Oncol (2012) 2.95
Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol (2012) 2.90
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Body mass index trajectory classes and incident asthma in childhood: results from 8 European Birth Cohorts--a Global Allergy and Asthma European Network initiative. J Allergy Clin Immunol (2013) 1.71
[New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene]. Ugeskr Laeger (2006) 1.39
Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat Genet (2011) 1.39
[Skin prick tests of patients with hay fever carried out in general practices compared with those carried out in a specialist outpatient clinic]. Ugeskr Laeger (2006) 1.38
The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype. Eur J Haematol (2007) 1.33
Clinical thresholds to egg, hazelnut, milk and peanut: results from a single-center study using standardized challenges. Ann Allergy Asthma Immunol (2012) 1.25
Soybean (Glycine max) allergy in Europe: Gly m 5 (beta-conglycinin) and Gly m 6 (glycinin) are potential diagnostic markers for severe allergic reactions to soy. J Allergy Clin Immunol (2008) 1.23
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities. Haematologica (2011) 1.15
Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha. Leuk Res (2013) 1.10
Wheat IgE-mediated food allergy in European patients: alpha-amylase inhibitors, lipid transfer proteins and low-molecular-weight glutenins. Allergenic molecules recognized by double-blind, placebo-controlled food challenge. Int Arch Allergy Immunol (2007) 1.07
Autoimmune pulmonary alveolar proteinosis: treatment options in year 2013. Respirology (2013) 1.06
Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay. J Mol Diagn (2011) 1.06
Threshold levels in food challenge and specific IgE in patients with egg allergy: is there a relationship? J Allergy Clin Immunol (2003) 1.02
Factors affecting the determination of threshold doses for allergenic foods: how much is too much? J Allergy Clin Immunol (2002) 1.01
High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma. Am J Surg Pathol (2012) 1.01
The association between early sensitization patterns and subsequent allergic disease. The DARC birth cohort study. Pediatr Allergy Immunol (2009) 1.00
Development of atopic dermatitis in the DARC birth cohort. Pediatr Allergy Immunol (2009) 0.99
Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden. Hematology (2009) 0.98
Microarray-based classification of diffuse large B-cell lymphoma. Eur J Haematol (2005) 0.97
Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma. Blood (2011) 0.95
Food allergy to apple and specific immunotherapy with birch pollen. Mol Nutr Food Res (2004) 0.95
Eosinophilic oesophagitis in infants and children in the region of southern Denmark: a prospective study of prevalence and clinical presentation. J Pediatr Gastroenterol Nutr (2010) 0.94
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study. J Invest Dermatol (2014) 0.94
Does absorption across the buccal mucosa explain early onset of food-induced allergic systemic reactions? J Allergy Clin Immunol (2005) 0.93
The prevalence of acute cutaneous drug reactions in a Scandinavian university hospital. Acta Derm Venereol (2006) 0.92
One-week oral challenge with penicillin in diagnosis of penicillin allergy. Acta Derm Venereol (2012) 0.92
The prevalence of allergic diseases in an unselected group of 6-year-old children. The DARC birth cohort study. Pediatr Allergy Immunol (2008) 0.92
NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression. Eur J Haematol (2011) 0.92
Recall Bias in Childhood Atopic Diseases Among Adults in The Odense Adolescence Cohort Study. Acta Derm Venereol (2015) 0.91
High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burden. Hematology (2008) 0.91
A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Br J Haematol (2013) 0.89
Circulating KIT D816V mutation-positive non-mast cells in peripheral blood are characteristic of indolent systemic mastocytosis. Eur J Haematol (2012) 0.88
Eosinophilia in routine blood samples and the subsequent risk of hematological malignancies and death. Am J Hematol (2013) 0.87
Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another "double hit" lymphoma with very poor outcome? Oncotarget (2014) 0.87
A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia. Br J Haematol (2013) 0.87
Epidemiology of systemic mastocytosis in Denmark. Br J Haematol (2014) 0.87
Prognostic significance of metallothionein in B-cell lymphomas. Blood (2006) 0.86
Clinical characteristics of soybean allergy in Europe: a double-blind, placebo-controlled food challenge study. J Allergy Clin Immunol (2007) 0.86
FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies. Clin Transl Allergy (2012) 0.86
Wheat allergy: a double-blind, placebo-controlled study in adults. J Allergy Clin Immunol (2006) 0.85
Nickel sensitization in adolescents and association with ear piercing, use of dental braces and hand eczema. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis (TOACS). Acta Derm Venereol (2002) 0.84
Multiple self-healing squamous epithelioma in different ethnic groups: more than a founder mutation disorder? J Invest Dermatol (2007) 0.84
Systemic mastocytosis--a systematic review. Dan Med J (2012) 0.84
Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate. Pediatr Blood Cancer (2010) 0.83
Rapid resolution of erythema marginatum after icatibant in acquired angioedema. Acta Derm Venereol (2011) 0.82
Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis. Eur J Haematol (2013) 0.82
The prevalence of peanut sensitization and the association to pollen sensitization in a cohort of unselected adolescents--The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis (TOACS). Pediatr Allergy Immunol (2005) 0.82
Angioedema--assessment and treatment. Tidsskr Nor Laegeforen (2012) 0.82
The diagnostic accuracy of the atopy patch test in diagnosing hypersensitivity to cow's milk and hen's egg in unselected children with and without atopic dermatitis. J Am Acad Dermatol (2004) 0.81
Anaphylaxis caused by mosquito allergy in systemic mastocytosis. Lancet (2013) 0.81
KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis. J Allergy Clin Immunol (2013) 0.81
Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations. J Allergy Clin Immunol (2012) 0.81
Nickel allergy from adolescence to adulthood in the TOACS cohort. Contact Dermatitis (2013) 0.81
Effects of antihistamines on innate immune responses to severe bacterial infection in mice. Int Arch Allergy Immunol (2011) 0.81
Soybean allergen detection methods--a comparison study. Mol Nutr Food Res (2008) 0.81
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives. Wien Klin Wochenschr (2012) 0.80
Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population-based cohort study. Br J Haematol (2013) 0.80
KIT D816V mutation-positive cell fractions in lesional skin biopsies from adults with systemic mastocytosis. Dermatology (2013) 0.80
Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups. Eur J Haematol (2007) 0.80
A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis. Haematologica (2014) 0.80
A randomized, double-blinded, placebo-controlled oral challenge study to evaluate the allergenicity of commercial, food-grade fish gelatin. Food Chem Toxicol (2004) 0.80
Risk assessment of clinical reactions to legumes in peanut-allergic children. World Allergy Organ J (2008) 0.80
Anti-irritants I: Dose-response in acute irritation. Contact Dermatitis (2006) 0.80
Positive nickel patch tests in infants are of low clinical relevance and rarely reproducible. Pediatr Allergy Immunol (2013) 0.80
Extreme neutrophil granulocytosis in a patient with anaplastic large cell lymphoma of T-cell lineage. APMIS (2007) 0.79
Imported melioidosis in Danish travellers: a diagnostic challenge. Scand J Infect Dis (2010) 0.79
Allergic contact dermatitis from oleyl alcohol in Elidel cream. Contact Dermatitis (2006) 0.79
A comparative study of the allergenic potency of wild-type and glyphosate-tolerant gene-modified soybean cultivars. APMIS (2004) 0.79
The development of the MeDALL Core Questionnaires for a harmonized follow-up assessment of eleven European birth cohorts on asthma and allergies. Int Arch Allergy Immunol (2014) 0.79
Cutaneous adverse drug reactions seen at a university hospital department of dermatology. Acta Derm Venereol (2006) 0.79
Validation of putative reference genes for normalization of Q-RT-PCR data from paraffin-embedded lymphoid tissue. Diagn Mol Pathol (2009) 0.79
Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy. Int Arch Allergy Immunol (2015) 0.78
Type I sensitization in adolescents: prevalence and association with atopic dermatitis. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis (TOACS). Acta Derm Venereol (2003) 0.78
Anti-irritants II: Efficacy against cumulative irritation. Contact Dermatitis (2006) 0.78
Substantial effect of topical cidofovir 1% on recalcitrant warts in a renal-transplanted adolescent: a case report. Transplantation (2011) 0.78
Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia. Leuk Lymphoma (2012) 0.78